Cellular resistance to an oncolytic virus is driven by chronic activation of innate immunity

Alejandra Larrieux1, Rafael Sanjuán1

  • 1Institute for Integrative Systems Biology (I2SysBio), Universitat de València-CSIC, Paterna, València 46980, Spain.

Iscience
|January 2, 2023
PubMed

Insights

Cellular resistance to oncolytic viruses can hinder cancer virotherapy. Researchers identified conserved gene expression changes, including interferon-stimulated genes, conferring cross-resistance to viruses in melanoma and colon carcinoma cells.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Cellular resistance to oncolytic viruses is a significant challenge for cancer virotherapy.
  • Understanding resistance mechanisms is crucial for improving treatment efficacy.

Purpose of the Study:

  • To investigate the mechanisms of cellular resistance to oncolytic vesicular stomatitis virus (VSV-D51) in cancer cells.
  • To identify genetic factors and pathways involved in acquired viral resistance.

Main Methods:

  • Isolation and characterization of resistant B16 mouse melanoma cell lines.
  • RNA sequencing (RNA-seq) to analyze global gene expression changes.
  • Assessment of cross-resistance to different viruses.

Main Results:

  • Resistant cells exhibited broad gene expression changes, notably chronic upregulation of interferon-stimulated genes.
  • Activated innate immunity in resistant cells conferred cross-resistance to VSV and Sindbis virus.
  • Identified novel differentially expressed genes (Mnda, Psmb8, Btn2a2) potentially involved in antiviral response.
  • Observed conserved transcriptomic changes in B16 and CT26 cell lines, suggesting predictable resistance mechanisms.

Conclusions:

  • Cellular resistance to oncolytic viruses involves conserved genetic mechanisms, potentially predictable.
  • Upregulation of interferon-stimulated genes and innate immunity activation are key features of resistance.
  • Further research into identified genes may reveal novel antiviral functions and therapeutic targets.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
874
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.9K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
69.6K